BiventRicular Pacing in prolongEd Atrio-Ventricular intervaL: the REAL-CRT Study

Sponsor
Gianluca Botto (Other)
Overall Status
Unknown status
CT.gov ID
NCT02150538
Collaborator
(none)
164
1
2
39
4.2

Study Details

Study Description

Brief Summary

This study was designed to evaluate the potential benefits of treatment with biventricular device in patients with normal systolic function , indication for pacing and impaired atrio-ventricular conduction , by comparing the treatment with dual-chamber device . The REAL -CRT study is designed to test the hypothesis that, in patients with atrioventricular block of I degree and standard pacing indications , biventricular pacing is superior to single stimulation of the right ventricle (RV) with optimized algorithms for minimization of pacing , as assessed by echocardiography an endpoint defined in terms of maintenance over time of left ventricular ejection fraction (LVEF ) and left ventricular end-systolic volume ( LVESV ) .

Condition or Disease Intervention/Treatment Phase
  • Device: Cardiac resynchronization therapy pacemaker
  • Device: Dual chamber pacemaker
N/A

Detailed Description

Clinical data suggest that biventricular pacing is able to preserve the myocardial performance more effectively than the right ventricular pacing in patients with atrioventricular block and mild systolic dysfunction . In particular, some studies have shown that medical therapy in these patients could be responsible for an increase in the cumulative percentage of chronic pacing over the 40% threshold , the threshold associated with a higher incidence of atrial fibrillation and hospitalization for heart failure and ventricular arrhythmias . In addition , patients with pre-existing left ventricular dysfunction and indication for pacing standards have improved left ventricular systolic function , exercise capacity and quality of life as a result of biventricular pacing as compared with Right ventricular pacing . These results suggest that biventricular pacing is a feasible option for permanent pacing in patients who have normal systolic function of the left ventricle and that this can be altered from the adverse effects of conventional Right ventricular pacing on systolic function of the left ventricle . This reality has prompted physicians to assess the value and role of cardiac resynchronization therapy (CRT ) in patients with prolonged Atrio-Ventricular (AV) conduction . Note the deleterious effects of chronic stimulation of the right ventricle , the optimal pacing mode should always be considered in these patients at the time of implantation . This study was designed to evaluate the potential benefits of treatment with biventricular device in patients with normal systolic function , indication for pacing and impaired atrio-ventricular conduction, by comparing it with the treatment with dual chamber device

Study Design

Study Type:
Interventional
Anticipated Enrollment :
164 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
BiventRicular Pacing in prolongEd Atrio-Ventricular intervaL: the REAL-CRT Study
Study Start Date :
Sep 1, 2013
Anticipated Primary Completion Date :
Dec 1, 2016
Anticipated Study Completion Date :
Dec 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Right ventricular stimulation

patients with conventional Right Ventricular Stimulation (only RV) with optimized algorithms for minimization of pacing

Device: Dual chamber pacemaker
right ventricular stimulation with dual chamber pacemaker

Experimental: Biventricular Stimulation

Patients with biventricular stimulation (Right Ventricle and Left Ventricle)

Device: Cardiac resynchronization therapy pacemaker
biventricular stimulation with cardiac resynchronization therapy pacemaker (crt-p)

Outcome Measures

Primary Outcome Measures

  1. LVEF [2 years]

    LVEF (Left Ventricular Ejection Fraction: such as the assessment of systolic function of the left ventricle)

  2. LVESV [2 years]

    LVESV (Left Ventricular End Systolic Volume: such as the assessment of left ventricular remodeling)

Secondary Outcome Measures

  1. echocardiographic left ventricular measures [2 years]

    . Structure and cardiac function: Left ventricular End Systolic Diameter, Left ventricular End Diastolic Diameter Left Ventricular End Systolic

  2. Echocardiographic altrial measures [2 years]

    Size of the left atrium (diameter and volume)

  3. Clinical outcome [2 years]

    Clinical benefit: 6 minute walking test quality of life questionnaire New York Heart Association class number and duration of hospitalizations

  4. Atrial fibrillation (AF) [2 years]

    Incidence of AF: incidence of persistent AF burden of FA new onset of AF

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients with standard indications to stimulation with a high probability of paced beats according to the clinical evaluation of the investigators:

  • First degree AV block (PR ≥ 220 ms) and indication for pacing

  • Paroxysmal AV block second degree (Type I and Type II) associated with long-PR (PR ≥ 220 ms)

  • Patient must be able to attend all required follow-up visits at the study center.

  • LVEF> 35%

Exclusion Criteria :
  • Patient is less than 18 years of age.

  • Patients with a life expectancy less than 12 months

  • Indication for CRT in class I and II

  • Third-degree AV block

  • Patients currently enrolled in other studies / logs

  • Patients who are not able to understand and sign an informed consent

  • State of current or planned pregnancy within 12 months of enrollment

  • Inability to understand and complete the questionnaire QOL

Contacts and Locations

Locations

Site City State Country Postal Code
1 Azienda Ospedaliera Sant'Anna Como Italy 22100

Sponsors and Collaborators

  • Gianluca Botto

Investigators

  • Principal Investigator: Gianluca Botto, S. Anna Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Gianluca Botto, Head of Electrophysiology Unit, S. Anna Hospital
ClinicalTrials.gov Identifier:
NCT02150538
Other Study ID Numbers:
  • Parere Unico 86/13
First Posted:
May 30, 2014
Last Update Posted:
Apr 21, 2016
Last Verified:
Apr 1, 2016
Keywords provided by Gianluca Botto, Head of Electrophysiology Unit, S. Anna Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 21, 2016